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Abstract
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a severe human disease caused by mutations in TYMP,
the gene encoding thymidine phosphorylase (TP). It belongs to a broader group of disorders characterized by a pronounced
reduction in mitochondrial DNA (mtDNA) copy number in one or more tissues. In most cases, these disorders are caused by
mutations in genes involved in deoxyribonucleoside triphosphate (dNTP) metabolism. It is generally accepted that
imbalances in mitochondrial dNTP pools resulting from these mutations interfere with mtDNA replication. Nonetheless, the
precise mechanistic details of this effect, in particular, how an excess of a given dNTP (e.g., imbalanced dTTP excess
observed in TP deficiency) might lead to mtDNA depletion, remain largely unclear. Using an in organello replication
experimental model with isolated murine liver mitochondria, we observed that overloads of dATP, dGTP, or dCTP did not
reduce the mtDNA replication rate. In contrast, an excess of dTTP decreased mtDNA synthesis, but this effect was due to
secondary dCTP depletion rather than to the dTTP excess in itself. This was confirmed in human cultured cells,
demonstrating that our conclusions do not depend on the experimental model. Our results demonstrate that the mtDNA
replication rate is unaffected by an excess of any of the 4 separate dNTPs and is limited by the availability of the dNTP
present at the lowest concentration. Therefore, the availability of dNTP is the key factor that leads to mtDNA depletion
rather than dNTP imbalances. These results provide the first test of the mechanism that accounts for mtDNA depletion in
MNGIE and provide evidence that limited dNTP availability is the common cause of mtDNA depletion due to impaired
anabolic or catabolic dNTP pathways. Thus, therapy approaches focusing on restoring the deficient substrates should be
explored.
Citation: Gonza´lez-Vioque E, Torres-Torronteras J, Andreu AL, Martı´ R (2011) Limited dCTP Availability Accounts for Mitochondrial DNA Depletion in
Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE). PLoS Genet 7(3): e1002035. doi:10.1371/journal.pgen.1002035
Editor: Nils-Go¨ran Larsson, Max Planck Institute for Biology of Aging, Germany
Received November 16, 2010; Accepted February 7, 2011; Published March 31, 2011
Copyright:  2011 Gonza´lez-Vioque et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Spanish Instituto de Salud Carlos III (PS09/01591 to RM, PI07/0347 to ALA, and a Sara Borrell fellowship to EG-V). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rmarti@ir.vhebron.net
Introduction
Mitochondrial DNA depletion syndrome refers to a group of
inherited metabolic disorders that considerably differ in their
clinical expression and genetic origin [1]. These are rare, but
severe diseases with no effective treatment, and patients die in the
early infancy in most cases. Four of the 9 genes known to be
associated with this group of disorders to date are directly involved
in the metabolism of deoxyribonucleoside triphosphates (dNTPs),
required for mtDNA replication [2–5]. Two of these genes (TK2,
Entrez Gene ID 7084, and DGUOK, Entrez Gene ID 1716) encode
the mitochondrial enzymes thymidine kinase 2 (TK2) and
deoxyguanosine kinase (dGK), which catalyze the first step in
mitochondrial salvage of pyrimidine and purine deoxyribonucleo-
sides, respectively. RRM2B (Entrez Gene ID 50484) encodes the
p53-inducible small subunit (p53R2) of ribonucleotide reductase
(RNR), the key enzyme in de novo synthesis of deoxyribonucleo-
tides. A p53-independent small subunit of RNR is highly expressed
in dividing cells, but is degraded and its expression downregulated
in quiescent cells; thus, the de novo supply of dNTPs for
mitochondrial DNA (mtDNA) replication is dependent on
p53R2 [6]. Mutations in the fourth gene, TYMP (Entrez Gene
ID 1890), encoding thymidine phosphorylase, cause mitochondrial
neurogastrointestinal encephalomyopathy (MNGIE, OMIM ID
#603041) [4]. Dysfunction of this cytosolic enzyme causes
expansion of the dTTP pool [7].
dNTP supply for mtDNA replication (Figure 1) depends on
intramitochondrial salvage of deoxyribonucleosides, or on the
mitochondrial import of deoxyribonuceloside phosphates from the
cytosol, made de novo from ribonucleotide reduction or from
cytosolic deoxyribonucleoside salvage. These pathways are
interconnected and the relative contributions of each pathway
depend on a number of different factors, most importantly, the cell
cycle (reviewed in [8]). It is generally assumed that imbalances in
the mitochondrial dNTP pools interfere with the correct mtDNA
replication and/or repair [1,8], but there is no experimental
evidence on the particular consequences of such imbalances on
mtDNA replication. The precise mechanistic details of this effect
remain largely unknown; the foreseeable depletion of dNTPs
resulting from a loss of function of TK2, dGK and RNR fits well
with mtDNA depletion syndrome, since dNTPs are the substrates
of mtDNA replication, but it is unclear how an excess of a given
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dNTP, specifically the dTTP expansion associated to thymidine
phosphorylase dysfunction in MNGIE, might lead to mtDNA
depletion. Other groups have reported the effects of thymidine
addition on dNTP pools in cell culture. It has long been known
that, in cycling cells, millimolar concentrations of thymidine cause
pronounced dCTP depletion due to the allosteric effects of an
expanded dTTP pool on RNR, which strongly inhibit the nuclear
DNA replication rate [9]. More recently, several studies have
shown that micromolar thymidine concentrations, similar to those
found in MNGIE patients, result in slight to moderate cytosolic
and mitochondrial dCTP depletion in cycling and quiescent
cultured cells [10–12].
Here, we studied the consequences of dNTP imbalances on
mtDNA replication in two different experimental models, and
found that the limited availability of one dNTP is a common
mechanism accounting for mtDNA depletion even under dTTP
excess. The replication is limited by the availability of the dNTP
present at the lowest concentration and, in the case of dTTP
excess, secondary dCTP depletion accounts for the reduction of
mtDNA replication rate.
Results/Discussion
We used an in organello replication approach [13] to investigate
whether excess of any of the 4 dNTPs affects mtDNA replication,
measured by incorporation of radiolabel from [3H]-dNTP or
[a-32P]-dNTP into mtDNA. Through controlled addition of the 4
dNTPs to the reaction, this model enabled us to study the
consequences of experimentally designed mitochondrial dNTP
imbalances on mtDNA replication. To assess modifications of the
intra-mitochondrial dNTP pool resulting from addition of each
dNTP to a mitochondrial suspension, mitochondria were
extracted from liver of C57BL/6J mice, endogenous dNTPs were
measured, and the effect of adding no dNTPs, 1 mM of all 4
dNTPs, and 100 mM of each dNTP was studied (Table 1). All 4
endogenous dNTPs were partially depleted over 2 hours of in
organello reaction. While dCTP was the most abundant endogenous
nucleotide in fresh mitochondria, it became the least plentiful at
the end. Addition of 1 mM of extramitochondrial dNTPs led to 4-
fold to 7-fold increases in intramitochondrial dNTPs after 2-hour
incubation. Addition of 100 mM of dTTP, dCTP, or dGTP
resulted in a 100-fold to 270-fold increase in the amount of each
nucleotide; when 100 mM dATP was added, a much larger
increase (,600-fold) was observed in the intramitochondrial
amount of this nucleotide. These results were independently
investigated by measuring the radioactivity incorporated into
mitochondria when 100 mM of tritium-labeled dNTPs were added
to the reaction. We found that 2 to ,6.5 times more dATP (or its
dephosphorylated derivatives) entered the mitochondria than
dTTP, dCTP, or dGTP (Figure S1). The enhanced transport
observed when dATP was added in large excess might be
mediated by the abundant ADP/ATP carrier; it has long been
known that dADP and dATP can be substrates of this
ribonucleotide transporter [14,15]. Interestingly, comparison of
these results with those of Table 1 shows that most dNTP
molecules transported into mitochondria are partially or totally
dephosphorylated.
Using this model, a 100-fold increase of dATP or dCTP
concentrations in the reaction did not produce detectable changes
Figure 1. Schematic representation of the metabolic pathways
that supply dNTPs for mtDNA replication. dThd: thymidine; dCtd:
deoxycytidine; dAdo: deoxyadenosisne; dGuo: deoxyguanosine; TP:
thymidine phosphorylase; TK1 (cytosolic) and TK2 (mitochondrial)
thymidine kinases; dGK: deoxyguanosine kinase; dCK: deoxycytidine
kinase; cdN and mdN: cytosolic and mitochondrial deoxynucleotidases;
dCTD: dCMP deaminase; TS thymidylate synthase; RNR: ribonucleotide
reductase. ENT1: equilibrative nucleoside transporter 1, which has been
found in human mitochondria [30,31]. The circle with a question mark
indicates evidence of a highly concentrative dTMP transport [32] by an
unidentified carrier. A dCTP transport activity has also been reported
[21]. Enzymes involved in mtDNA depletion syndrome are highlighted
in grey.
doi:10.1371/journal.pgen.1002035.g001
Author Summary
Mitochondria are subcellular organelles that constitute the
main energy supply within the cell. They contain their own
DNA, which should be continuously replicated to ensure
the correct mitochondrial function. Several mitochondrial
diseases are caused by genetic defects that compromise
this replication and result in mitochondrial DNA depletion.
In most cases, these genetic defects block the synthesis of
dATP, dGTP, dCTP, and dTTP, the 4 nucleotides needed for
mitochondrial DNA replication. However, for one of these
disorders (mitochondrial neurogastrointestinal encephalo-
myopathy, MNGIE), the biochemical pathways needed to
synthesize them are intact, but degradation of dTTP is
genetically blocked, leading to dTTP accumulation. We
investigated the biochemical mechanisms through which
the dTTP excess leads to mitochondrial DNA depletion in
MNGIE, and we found that the delay of mitochondrial DNA
replication rate observed when dTTP is in excess is not
caused by this excess in itself. Instead, the dTTP overload
produces a secondary dCTP depletion that actually delays
mitochondrial DNA replication. Therefore, the common
factor accounting for mitochondrial DNA depletion in
these disorders is the limited availability of one or more
nucleotides. This indicates that strategies to provide
nucleotides to patients’ mitochondria should be explored
as a possible treatment for these fatal disorders.
Limited dCTP Accounts for mtDNA Depletion in MNGIE
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in mtDNA replication, measured by incorporation of 3H or 32P
into mtDNA, whereas excess dGTP induced a 45% increase
(Figure 2A, 2B, 2C). The same excess of dTTP, however, caused a
significant 25% decrease in mtDNA replication. Thus, only dTTP
excess had a negative effect on mtDNA replication. In an early
study it was reported that addition of thymidine to Chinese
Table 1. Effect of exogenous dNTP addition on intramitochondrial dNTP pools.
Before reaction After 2 h reaction, when added:
1 mM each dNTP plus 100 mM of:
No addition No addition 1 mM each dNTP dATP dTTP dCTP dGTP dThd
dATP 1.4160.35 0.6360.14 4.6260.22 405648 4.6660.91 ND ND 3.5560.73
dTTP 2.2860.33 0.3060.06 1.3160.60 ND 37.564.5 ND ND 5.2561.71 **
dCTP 7.5361.57 0.2260.09 1.3760.58 ND 0.8560.20 * 59.5611.1 ND 0.6860.37 **
dGTP 1.2260.19 0.4560.07 2.5160.81 ND 2.3060.70 ND 52.865.4 2.0260.44
Results expressed in pmoles/mg prot, as mean6SD of N = 3 experiments, except for (*) (N = 5) and (**) (N = 4). ND: not determined.
doi:10.1371/journal.pgen.1002035.t001
Figure 2. dTTP excess causes a decrease of in organello mtDNA synthesis associated with secondary dCTP depletion. Concentrations (mM) of
dNTPs added to the reaction are indicated in the tables attached to the panels. Dashes: no dNTP addition. Asterisks: radiolabeled nucleotide. All results
(except panel E) were obtained after 2 hours of in organello reaction. Bars represent mean6SD. A. Effect of an excess of each dNTP on mtDNA replication.
Tritium-labeled dATP or dGTP were used. The reference result (open bar) is plotted as the mean of all the experiments, equaled to 100%, the error bar
indicates the SD as percentage. P values obtained with the Wilcoxon T-test. B. Representation of AccI-digested mouse mtDNA. OH, origin of heavy strand
replication. OL, origin of light strand replication. Dotted lines, fragments visualized in the gels in panel C, which show the bands resulting from the AccI-
digestion; [a32P]-labeled DNA was extracted, AccI-digested, and electrophoresed. The top (32P) and bottom (EtBr) gels show the radioactive signal and
ethidium bromide staining, respectively. The even distribution of radioactivity in the 3 bands (here and Figure 3B) indicates that de novo replication in our
model is distributed thorough the entire mtDNA, in contrast to other situations in which the 7S-fragment is preferentially replicated [33]. D. Effect of dTTP
excess on mitochondrial dNTP pools. P values obtained with Mann-Whitney U test. E. Effect of dTTP excess on transport of radioactive label from exogenous
1 mM [5,59-3H]dCTP to mitochondria. Radioactivity of the mitochondrial pellet was measured and apparent pmoles were estimated from the specific
radioactivity of dCTP. F. dTTP-induced decrease of mtDNA replication in the absence of exogenous dCTP and dGTP. P values obtained with Wilcoxon T-test.
doi:10.1371/journal.pgen.1002035.g002
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hamster ovary cells leads to an increase in the dTTP pool and
cessation of nuclear DNA replication, resulting from dCTP
depletion [9]. More recently, several reports have shown
reductions in cellular or mitochondrial dCTP in parallel to dTTP
expansion following thymidine overload in cultured cells [10–12].
We then measured the 4 dNTPs in the presence of dTTP overload
to determine whether additional mitochondrial dNTP imbalances
were produced in our model. A significant decrease in dCTP
concentration was observed in association with dTTP excess, with
no effect on dATP or dGTP (Table 1 and Figure 2D). The dCTP
contraction was not caused by an inhibitory effect of the large
dTTP excess on transport of the exogenously provided dCTP
because incorporation of [5,59-3H]dCTP label into mitochondria
was not affected by increasing amounts of dTTP (Figure 2E).
We tested the influence of dTTP overload on mtDNA
replication in 2 additional conditions: 1) without adding dCTP
and 2) without adding either dCTP or dGTP (Figure 2F). The
inhibitory effect of dTTP on mtDNA replication was also observed
in the absence of exogenous dCTP, thus confirming that this effect
is not caused by inhibition of dCTP transport by an excess of
dTTP. The effect of dTTP overload (100 mM added) on the
endogenous dCTP pool at the end of the reaction was tested in 5
independent experiments, which also revealed dCTP contraction
(by 56.4%620.6%; P=0.016, Mann-Whitney U test). In contrast,
dTTP overload did not influence mtDNA replication when
exogenous dCTP and dGTP were both omitted, probably because
endogenous dGTP is the limiting substrate of the reaction. This is
consistent with the fact that dGTP is present in the lowest
concentration in freshly isolated mitochondria (Table 1). In
keeping with this concept, dGTP was the only dNTP that, in
excess, stimulated mtDNA replication (Figure 2A).
Two alternative mechanisms could account for the negative
effect of dTTP excess on mtDNA replication: 1) dTTP overload,
in itself, may slow down the replication machinery, or 2) secondary
dCTP depletion may restrict replication because dCTP becomes
the limiting substrate. To test these alternatives, we attempted to
restore mtDNA replication by supplying additional dCTP to a
reaction under dTTP excess. As shown in Figure 3A, 3B, the dose-
dependent negative effect of dTTP on mtDNA replication was
prevented, also in a dose-dependent manner, by dCTP supple-
mentation. Addition of dATP or dGTP failed to prevent the
negative effect of dTTP (Figure 3C), even though dGTP had an
Figure 3. dTTP- and thymidine-induced decrease in mtDNA replication is prevented by dCTP supplementation. Concentrations (mM)
of dNTP or nucleosides added to the reaction are indicated in the tables attached to the panels. Dashes: no addition. Asterisks: radiolabeled
nucleotide. All results were obtained after 2 hours of in organello reaction. Bars represent mean6SD. dThd: thymidine; dCtd: deoxycytidine. A, B.
mtDNA synthesis in the presence of increasing amounts of dTTP and dCTP; 3H-labeled DNA was quantified in (A) or 32P-labeled DNA was AccI-
digested and resolved in (B). C. Supplementation with dCTP excess (but not dATP or dGTP excess) prevented dTTP-induced decrease in mtDNA
replication. D. Effect of thymidine excess on mtDNA replication. P values obtained with Wilcoxon T-test. E. Effect of thymidine excess on
mitochondrial dNTP pools. P values obtained with Mann-Whitney U test. F. Thymidine-induced decrease of mtDNA replication was prevented by
supplementation with excess of deoxycytidine or dCTP. P values obtained with Wilcoxon T-test.
doi:10.1371/journal.pgen.1002035.g003
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independent positive effect, as was mentioned above (Figure 2A).
This positive effect was not due to a dGTP-induced dCTP
increase, because the addition of 100 mM dTTP induced similar
reductions of dCTP levels both in the absence (0.8560.20 pmol/
mg prot, from Table 1) and in the presence (0.7160.20 pmol/mg
prot; N=3) of 100 mM dGTP. Monitoring mtDNA replication
over 2 hours showed that the dGTP-induced positive effect was
very pronounced in the initial phase (first 30 min), and very
reduced or negligible during the second hour (Figure S2),
suggesting that, in our model, dGTP concentration is the limiting
factor only in the initial phase of the replication.
These results demonstrate that the decrease in mtDNA
replication occurring under dTTP overload in our model is
caused by secondary dCTP depletion, rather than by dTTP
excess. We postulate that progression of mtDNA replication in
organello is limited by the availability of each dNTP substrate. This
notion is supported by 3 observations: 1) dGTP, the endogenous
nucleotide in lowest concentration, was the only dNTP that, in
excess, stimulated mtDNA replication (Figure 2A), 2) no positive
or negative effect was observed by dTTP excess in the absence of
exogenous dGTP (Figure 2F), and 3) mtDNA replication was
sensitive to removal of each separate exogenous dNTP (Figure S3).
The primary biochemical imbalance in thymidine phosphory-
lase-deficient MNGIE patients is systemic accumulation of
thymidine, which leads to expansion of the dTTP pool in cultured
cells [10–12] and in vivo [7]. The results reported above indicate
that most triphosphate molecules entering the mitochondria lose
one or more phosphates. Therefore, we tested whether the effect of
thymidine overload in our in organello reaction caused effects similar
to those observed with dTTP excess (Figure 3D, 3E, 3F).
Thymidine overload slowed down mtDNA replication, with and
without addition of 1 mM dCTP (Figure 3D) and, again, this effect
disappeared when dGTP addition was omitted. Addition of
extramitochondrial thymidine increased intramitochondrial
dTTP, revealing active in organello phosphorylation through
TK2, and decreased dCTP, paralleling the results obtained with
dTTP excess (Figure 3E). dATP and dGTP also showed a slight
trend to be reduced, but far from the ,50% reduction observed
for dCTP. Noteworthily, while intramitochondrial dTTP expan-
sion was moderate (3-fold) and far from the nearly 30-fold increase
observed when 100 mM of dTTP was added (Table 1), the extent
of the dCTP decrease was very similar, suggesting that dCTP
contraction may be caused mainly by thymidine rather than by
dTTP. Addition of deoxycytidine or dCTP restored mtDNA
replication in the presence of thymidine overload (Figure 3F), thus
confirming that thymidine excess, in itself, does not slow down
mtDNA replication.
Phosphorylation of thymidine and deoxycytidine is catalyzed by
the same mitochondrial kinase, TK2. Studies in the human
enzyme have shown that TK2-catalyzed deoxycytidine phosphor-
ylation is competitively inhibited by thymidine, and thymidine
phosphorylation is also inhibited (less effectively) by deoxycytidine,
while both are feedback-inhibited by dTTP and dCTP [16]
(Figure 4). Therefore, we would expect that dCTP excess and the
deoxycytidine generated by dCTP dephosphorylation, would also
reduce mtDNA replication. In our model, dCTP excess did not
affect mtDNA replication in the presence of dTTP (Figure 2A and
Figure 3C). However, when we repeated the experiment in the
absence of exogenous dTTP (Figure S4), addition of 100 mM
dCTP decreased mtDNA replication by 44.4% (64.3%), support-
ing the idea that the effects produced by dTTP and dCTP excesses
are both TK2-mediated.
Secondary dCTP depletion due to TK2 inhibition has been
suggested to occur in MNGIE [10,17]. The present report
provides the first direct evidence that thymidine-induced mito-
chondrial dCTP contraction, previously observed by others [10–
12], delays mtDNA replication in vitro, rather than dTTP excess.
We found that ,40% contraction of the mitochondrial dCTP
pool leads to decreased mtDNA replication in organello, while
dTTP increases as high 30-fold do not produce observable effects.
Previous in vivo observations are consistent with this mechanism.
Brain and liver mitochondrial dTTP were both found to be
increased in the double Tymp/Upp1 knockout murine model of
MNGIE, but mitochondrial dCTP depletion was only seen in
brain. Interestingly, brain, but not liver, had mtDNA depletion
[7], supporting the notion that dCTP depletion, and not dTTP
excess, is associated with mtDNA copy number decreases.
Thymidine overload is reported to cause mtDNA depletion in
human cultured cells [11]. Using the same model, we tested
whether addition of deoxycytidine prevents the negative effects of
thymidine in human cells. We found that mtDNA depletion
caused by 40 mM thymidine is prevented by co-treatment with
40 mM deoxycytidine (Figure 5). Similarly, after 30 days under
thymidine overload, mtDNA-depleted cells gradually recovered
mtDNA copy number when deoxycytidine was added to the
medium. Therefore, our results demonstrate that the negative
effect of thymidine on mtDNA in cultured human cells can be
prevented by deoxycytidine.
Despite the increasing number of studies investigating the
molecular mechanisms involved in mtDNA depletion syndrome,
many unsolved questions require further effort [1,8,18]. In the
case of MNGIE, other groups have developed models to study the
effect of thymidine overload on dNTP pools and on mtDNA
replication in cell culture [10–12]. Interestingly, all these studies
revealed moderate cytosolic and mitochondrial dCTP depletion
secondary to thymidine overload, as well as diverse effects on
Figure 4. Hypothetical mechanism accounting for decrease in
mtDNA replication caused by thymidine overload. TK2-catalyzed
deoxycytidine phosphorylation is inhibited competitively by thymidine
and noncompetitively by dTTP [16], leading to depletion of dCTP, which
becomes the limiting dNTP for mtDNA replication. ENT1: equilibrative
nucleoside transporter 1, which has been found in human mitochondria
[30,31]. The circle with a question mark indicates evidence of a highly
concentrative dTMP transport [32] by an unidentified carrier. mdN and
cdN: mitochondrial and cytosolic deoxynucleotidases. dThd: thymidine;
dCtd: deoxycytidine.
doi:10.1371/journal.pgen.1002035.g004
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mtDNA. After a long treatment (8 months) of HeLa cells with
thymidine, Song et al [12] found multiple deletions in mtDNA, but
failed to detect depletion, probably because the study was
performed using a highly proliferating cell line. More recently,
Pontarin et al [11] tested the effects of thymidine on quiescent lung
and skin fibroblasts, and mtDNA depletion, but not deletions, was
observed. Here, we have tried to address how dTTP expansion
and dCTP contraction contribute to the reduction of mtDNA
copy number using isolated murine mitochondria. This model
allowed us to study in controlled conditions the changes of the
replication rates induced by designed dNTP imbalances. Our
results indicate that mitochondrial dNTP availability is the key
factor for mtDNA maintenance in mtDNA depletion syndrome
caused by mutations in TYMP, TK2, DGUOK, and RRM2B. These
last 3 genes directly compromise the salvage or de novo supply of
mitochondrial dNTPs, in agreement with the clinical severity of
cases with TK2, DGUOK, and RRM2B mutations. In MNGIE
patients, however, all anabolic steps that provide mitochondrial
dNTPs for mtDNA replication are fully functional, and the main
factor accounting for the impaired replication is believed to be
dTTP excess caused by thymidine phosphorylase deficiency.
While this is likely true for the multiple deletions or somatic point
mutations generated by a dTTP-driven next nucleotide effect
[19,20], the experimental evidence presented here indicates that
mitochondrial dCTP depletion secondary to thymidine excess
accounts for mtDNA depletion, rather than dTTP excess.
Although using isolated mitochondria allowed us to easily study
the effect of dNTP imbalances on mtDNA replication, some
limitations derived from this simplified system should prompt one
to be cautious when interpreting the results. For example, isolated
mitochondria lack deoxycytidine kinase (dCK), the cytosolic
enzyme that catalyzes the phosphorylation of all deoxyribonucleo-
sides except deoxyuridine and thymidine, which do not inhibit
deoxycytidine phosphorylation by dCK. Our in organello system
is also lacking de novo dCDP (and other dNDPs) synthesis via RNR.
In cultured cells and in vivo, these pathways could compensate or
reduce the effect of the mitochondrial dCTP decay studied here,
because deoxyribonucleotides can be imported from the cytosol to
mitochondria [21]. However, as mentioned above, mitochondrial
dCTP depletion has been reported in cell culture and in in vivo
models of MNGIE [7,10–12], indicating that, at least in some cells
and tissues, this compensation does not suffice to normalize
mitochondrial dCTP levels. Further support came from our
recovery experiments in quiescent fibroblasts: cotreatment with
deoxycytidine largely prevented thymidine-induced mtDNA,
indicating that dCTP contraction should be the cause of the
thymidine-induced mtDNA depletion not only in isolated
mitochondria but also in cultured cells.
Therefore, the common biochemical condition in mitochondrial
DNA depletion syndrome due to imbalanced dNTP pools
(including MNGIE) is a limited availability of one or more
substrates for mtDNA replication. Based on this idea, therapy
approaches for this group of disorders should focus on supplying
the specific substrates that are depleted in each enzyme defect.
Previous studies have experimentally examined the potential
benefits of biochemically by-passing these enzyme defects.
Supplementation with purine deoxyribonucleoside monophos-
phates prevented mtDNA depletion in dGK-deficient cultured
cells [22,23]. In the case of MNGIE, the treatment relies on
providing thymidine phosphorylase activity through allogeneic
hematopoietic stem cell transplantation [24], but preventing
mitochondrial dCTP depletion could be a complementary
approach. Deoxycytidine supply would compensate for thymidine
competition for TK2-mediated phosphorylation, or the nucleoside
would be phosphorylated by dCK resulting in more cytosolic
deoxycytidine nucleotides available to be imported by mitochon-
dria. Both mechanisms would increase mitochondrial dCTP levels,
thus preventing the negative effects of dCTP depletion on mtDNA
replication. However, the optimal way to provide this precursor is
not obvious, because of the complicated interconnections between
the enzymes of dNTP metabolism. Enzymatic deamination would
limit the availability of deoxycytidine, as happens with deoxycy-
tidine analogues [25]. Cytidine deaminase inhibitors, alone or in
combination with deoxycytidine, would be an alternative [25],
because they would limit the conversion of endogenous or supplied
deoxycytidine to deoxyuridine. The availability of a murine model
of the disease [7] will enable us to test the potential benefits of
these approaches, and to find the way to avoid possible pitfalls.
Materials and Methods
This study was carried out in accordance with the rules
established by the Generalitat de Catalunya for the Care and Use of
Laboratory Animals. The protocol was approved by the
Committee on the Ethics of Animal Experiments of the Institut de
Recerca Hospital Universitari Vall d’Hebron (Permit Number: 58/09).
Figure 5. Thymidine-induced mtDNA depletion is prevented by deoxycytidine supplementation in human cultured cells. Influence of
thymidine and deoxycytidine supplementation on mtDNA copy number in quiescent primary human skin fibroblasts in culture. Cells were collected
at the times indicated and mtDNA/nDNA ratio was assessed. Results are plotted as percentages of the ratios obtained for parallel cultures with no
nucleoside addition. Error bars represent standard error of the mean of N independent experiments (N = 4 for squares and rhombs; N = 3 for circles
and triangles). dThd: thymidine; dCtd: deoxycytidine.
doi:10.1371/journal.pgen.1002035.g005
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In organello replication
Mitochondria were isolated as described [26] with minor
modifications. Two to 3-month-old male C57BL/6J mice were
killed by cervical dislocation and the liver was rapidly removed
and chilled in homogenization buffer (4 mL/g tissue, 320 mM
sucrose, 1 mM EDTA, 10 mM Tris-HCI, pH 7.4). All further
operations were carried out at 2–4uC using sterile solutions. The
liver was cut in small pieces, homogenized in a Dounce
homogenizer (4 up-and-down strokes), and spun at 1,0006g for
5 min. The supernatant was aliquoted in Eppendorf tubes and
centrifuged at 13,0006g for 2 min. The mitochondrial pellets
were washed 3 times in homogenization buffer and once in
incubation buffer (25 mM sucrose, 75 mM sorbitol, 100 mM KCl,
10 mM K2HPO4, 0.05 mM EDTA, 5 mM MgCl2, and 10 mM
Tris-HCl, pH 7.4). Lastly, the mitochondrial pellet was resus-
pended in 1 mL of incubation buffer and protein concentration
was determined (Coomassie Plus Assay Kit, Thermo Scientific,
Rockford IL). Samples containing 500 mg of protein were
resuspended in 250 mL of incubation buffer supplemented with
1 mM ADP, 10 mM glutamate, 2.5 mM malate and 1 mg/mL
fatty acid-free bovine serum albumin, as well as dNTPs at the
concentrations indicated for each experiment. The radiolabeled
nucleotides used were [8-3H]dATP, [8-3H]dGTP, or [5,59-3H]dCTP
(between 12–21 Ci/mmol) and [a-32P]dATP or [a-32P]dGTP
(100 Ci/mmol), depending on the experiment. In these conditions,
mitochondria were incubated at 37uC in a rotary shaker (in organello
reaction) for 2 h, unless otherwise indicated. Mitochondria were
then pelleted (13,0006g for 1 min) and washed twice with 10%
glycerol, 0.15 mM MgCl2, and 10 mM Tris-HCl (pH 6.8). DNA
was extracted from this pellet as described [27]. Briefly, the pellet
was lysed with 500 mL of 20 mM Hepes-NaOH, (pH 7.4) 75 mM
NaCl, 50 mM EDTA, 20 mg/mL proteinase K, and incubated at
4uC for 45 min. Then, 17 mL of 30% lauryl maltoside was added
and the mixture was incubated at 50uC for 45 min. Twenty-five mL
of the homogenate was used for scintillation counting (Beckman
Coulter LS 6500, Brea, CA) to quantify the total label within
mitochondria. These data allowed us to rule out that differences in
DNA labeling were due to differential amounts of radioactive
nucleotide transported into mitochondria. The remaining mito-
chondrial homogenate was used for phenol-chloroform extraction,
and DNA was dissolved in TE buffer (1 mM EDTA, 10 mM Tris-
HCl; pH 7.5) and quantified (Quant-iT PicoGreen dsDNA
Reagent, Invitrogen). The DNA-incorporated radiolabel was
measured by scintillation counting. De novo mtDNA replication
was quantified as the apparent fmoles of 3H-labeled nucleotide
per ng DNA, calculated from the specific radioactivity of the
radiolabeled nucleotide used.
In each assay, a reaction with 1 mM of each of the 4 dNTPs was
processed. This reference point was considered 100% and the
remaining results were expressed as a percentage. When 32P-
labeled dATP or dGTP were used, DNA was dissolved in 20 mM
Tris-acetate, 50 mM potassium acetate, 10 mM magnesium
acetate, and 1 mM dithiothreitol, pH 7.9, and digested with AccI
(New England Biolabs, Ipswich, MA). The product was resolved in
1% agarose gel in 40 mM Tris-acetate and 1 mM EDTA, pH 8.0,
stained with ethidium bromide to capture the total DNA image,
then washed in TE buffer and dried under vacuum. The
radiolabeled bands, representing de novo synthesized DNA, were
visualized by autoradiography and quantified (Image J software,
NIH).
Mitochondrial dNTP content determination
Mitochondria (500 mg of protein) were treated with 200 mL of
60% methanol and kept at 220uC for 2 h. The protein was
pelleted at 25,0006g for 10 min and the supernatant incubated at
100uC for 3 min, dried under speed vacuum and redissolved in
20–100 mL of water, depending on the expected dNTP concen-
tration (dNTP extract). dNTP content was determined using a
polymerase-based method [28] with minor modifications. Briefly,
20 mL of reaction mixture contained 5 mL of dNTP extract in
40 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 5 mM dithiothreitol,
0.25 mM oligoprimer, 0.75 mM [8-3H]dATP, 12–21 Ci/mmol (or
[methyl-3H]dTTP for the dATP assay) and 1.7 units of Thermo
Sequenase DNA Polymerase (GE Healthcare). Reaction mixtures
with aqueous dNTP standards were processed in parallel. After
incubation at 48uC for 60 min, 18 mL of the mix was spotted on a
Whatman DE81 paper and left to dry. The filters were washed 3
times for 10 min with 5% Na2HPO4, once with water, once with
absolute ethanol, and left to dry again. The retained radioactivity
was determined by scintillation counting, and dNTP amounts
calculated from interpolation on the calibration curves. To ensure
the reliability of the results, triplicates of 2 different dilutions
of each dNTP extract (usually undiluted and 1:3 water-diluted)
were processed in each independent experiment. When dATP
was determined in extracts with large amounts of dTTP
(37.564.5 pmol/mg protein, Table 1), which significantly dilutes
the label ([methyl-3H]dTTP) used for the assay [28], the dilution
was taken into account and the appropriate correction factor was
applied to the results.
Cell culture
Human primary skin fibroblasts (passage 4 or lower) from 4
healthy controls were seeded in 3.5-cm diameter plates (100,000
cells per plate) and expanded in Dulbecco’s modified Eagle’s
medium with 4.5 g/L glucose, supplemented with 2 mM L-
glutamine, 100 U/mL penicillin and streptomycin, and 10%
dialyzed FBS (Invitrogen) in a humidified incubator at 37uC and
5% CO2. Four days after tight confluence was reached, FBS was
reduced to 0.1%. Four days later (day 0) different plates were
maintained in the following conditions: 1) no added nucleosides, 2)
40 mM thymidine, and 3) 40 mM thymidine+40 mM deoxycyti-
dine. At day 30, 2 additional conditions were generated: 4)
thymidine withdrawal from condition 2, and 5) 40 mM deoxycy-
tidine added to condition 2. Media was replaced every 3 days to
ensure that thymidine and deoxycytidine concentrations were
always between 10 and 40 mM, as tested by HPLC. On different
days, cells were harvested by trypsinization, washed with
phosphate-buffered saline, pelleted and stored at 220uC until
DNA isolation.
Quantification of mtDNA copy number
DNA was isolated from cell pellets (QIAampDNA Mini kit,
Qiagen), dissolved in TE buffer, and quantified (NanoDrop
Spectrophometer, Thermo Scientific). Relative quantitation of
mtDNA (12S rRNA gene) versus nuclear DNA (RNase P single
copy gene) was performed using an ABI PRISMH 7500 real-time
PCR system (Applied Biosystems). Custom designed primers and
probe for the 12S rRNA gene were used for assessing mtDNA
copy number, which was expressed as the ratio over the copy
number of the RNase P single copy nuclear gene, as previously
described [29].
Supporting Information
Figure S1 Transport of radioactive label from exogenous
100 mM [8-3H]dATP, [8-3H]dGTP, [5,59-3H]dCTP or
[methyl-3H]dTTP into mitochondria after 2 hours of in organello
reaction. Radioactivity of the mitochondrial pellet was measured
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and apparent pmoles were estimated from the specific radioactiv-
ity of the dNTPs. Concentrations (mM) of dNTPs added to the
reaction are indicated in the attached table. Asterisks: radiolabeled
nucleotide. Bars represent mean6SD.
(PDF)
Figure S2 Monitoring of mtDNA synthesis over 2 hours with
dGTP and dTTP excess. Concentrations (mM) of dNTPs added to
the reaction are indicated in the table on the right. The replication
observed after 2 hours of reaction with 1 mM each dNTP added
(rhombs) is considered the reference point (100%). Error bars
represent6SD (N=3). Replication rates in the table at the bottom
are expressed as the percentage of replication per minute.
(PDF)
Figure S3 Effect of removing each single exogenous dNTP on
mtDNA synthesis. Concentrations (mM) of dNTPs added to the
reaction are indicated in the attached table. Dashes: no dNTP
addition. Asterisks: radiolabeled nucleotide. Results were obtained
after 2 hours of in organello reaction.
(PDF)
Figure S4 Effect of dCTP excess on mtDNA synthesis when
exogenous dTTP (or dTTP and dGTP) was omitted in the in
organello reaction. The dCTP-induced decrease of mtDNA
synthesis disappeared when dGTP was omitted, likely because
dGTP became the limiting substrate, as is suggested in Figure 2A
and 2F, and Figures S2 and S3. Bars represent mean6SD. The
reference result (open bar) is plotted as the mean of all the
experiments, equaled to 100% and the error bar indicates the SD
as percentage. P values obtained with the Wilcoxon T-test.
(PDF)
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